---
layout: minimal-medicine
title: Tolvaptan
---

# Tolvaptan
### Generic Name
Tolvaptan

### Usage
Tolvaptan is a medication used to treat hyponatremia, a condition characterized by abnormally low levels of sodium in the blood.  It's specifically indicated for hospitalized adults with clinically significant euvolemic or hypervolemic hyponatremia (serum sodium levels <125 mEq/L, or less severely low sodium that's causing symptoms and hasn't responded to fluid restriction).  This includes patients with heart failure, cirrhosis of the liver, and syndrome of inappropriate antidiuretic hormone (SIADH).  It's crucial to understand that Tolvaptan is *not* appropriate for patients needing immediate, rapid correction of low sodium levels to prevent serious neurological problems; its effectiveness in such situations hasn't been established.

### Dosage
**Adult Dosage:** Tolvaptan is administered orally. The initial dose is 15 mg once daily.  After at least 24 hours, the dose may be increased to 30 mg once daily, up to a maximum of 60 mg once daily, at 24-hour intervals to reach the desired serum sodium level.  Fluid restriction should be avoided during the first 24 hours of treatment.  It's crucial to note that Tolvaptan should not be used for more than 30 days due to the risk of liver damage (hepatotoxicity).

**Pediatric Dosage:** The safety and effectiveness of Tolvaptan in children have not been established.

**Dosage Adjustments:**  Dosage adjustments are necessary in certain situations:

* **Hepatic Impairment:** Tolvaptan should be avoided in patients with liver disease, including cirrhosis. Close monitoring for signs of liver damage is vital, and the medication should be stopped immediately if such symptoms appear.  The 30-day usage limit is especially important in these cases.
* **Renal Impairment:**  No dose adjustment is needed for patients with a creatinine clearance (CrCl) of â‰¥10 mL/min.  However, Tolvaptan is not recommended for those with CrCl <10 mL/min and is contraindicated in patients with anuria (absence of urine production).
* **Drug Interactions:**  The use of Tolvaptan with certain medications needs careful consideration.  Avoid use with moderate or strong CYP3A inhibitors (e.g., aprepitant, erythromycin, fluconazole, verapamil, ketoconazole, clarithromycin, ritonavir, saquinavir).  Strong CYP3A inducers (e.g., rifampin, barbiturates, phenytoin, carbamazepine, St. John's Wort) should also be avoided.  Dose reduction may be necessary with P-glycoprotein (P-GP) inhibitors (e.g., cyclosporine, quinidine).


### Side Effects
**Common Side Effects (occurring in more than 10% of patients):**

* Fatigue
* Dizziness
* Increased thirst
* Nausea
* Dry mouth (xerostomia)
* Diarrhea
* Increased urination (polyuria)

**Less Common but Serious Side Effects (occurring in 1-10% or less, but potentially serious):**

* Palpitations
* Stroke (cerebrovascular accident)
* Blood clots (deep vein thrombosis, pulmonary embolism)
* Irregular heartbeat (ventricular fibrillation)
* Skin rash
* Increased blood sodium levels (hypernatremia)
* Dehydration
* Low blood volume (hypovolemia)
* Liver damage (hepatotoxicity, increased ALT levels)
* Muscle breakdown (rhabdomyolysis)
* Respiratory failure

*Many other less frequent side effects are possible.  Consult a doctor immediately if you experience any adverse effects.*

### How it Works
Tolvaptan works by blocking the action of vasopressin (also known as antidiuretic hormone or ADH) at the V2 receptors in the kidneys.  Vasopressin normally signals the kidneys to retain water. By blocking this signal, Tolvaptan increases the excretion of water from the body, thus raising the concentration of sodium in the blood and correcting hyponatremia.

### Precautions
* **Contraindications:** Tolvaptan is contraindicated in patients with hypersensitivity to the drug, those unable to sense or respond to thirst, those with hypovolemic hyponatremia (low sodium due to low blood volume), those using strong CYP3A4 inhibitors, and those with anuria.  It's also contraindicated in patients requiring urgent correction of low sodium levels.
* **Warnings:** Tolvaptan should only be started and restarted in a hospital setting where serum sodium levels can be closely monitored. Rapid correction of hyponatremia can cause osmotic demyelination syndrome, a serious and potentially fatal condition.  There's an increased risk of hyperkalemia, central nervous system effects (dizziness, weakness, fainting), hepatotoxicity, and dehydration/hypovolemia.
* **Pregnancy and Breastfeeding:**  Tolvaptan is a Category C drug during pregnancy. Its excretion in breast milk is unknown, and breastfeeding is not recommended while using this medication.
* **Drug Interactions:**  See the Dosage Adjustments section for details on drug interactions.  Grapefruit juice can increase Tolvaptan levels in the blood.
* **Other Precautions:**  Patients should have access to water at all times to avoid dehydration. Therapy should be interrupted if the patient's ability to drink or access to water is limited.


### FAQs
* **Q: How long does it take to see results from Tolvaptan?** A:  The response time varies depending on individual factors. Serum sodium levels are closely monitored to guide dosage and treatment duration.

* **Q: Can I stop taking Tolvaptan suddenly?** A: No, consult your doctor before stopping the medication.  Sudden cessation may require adjustment of fluid balance.

* **Q: What should I do if I miss a dose?** A: Take the missed dose as soon as you remember, unless it's nearly time for the next dose. Do not double the dose.

* **Q: How should I store Tolvaptan?** A: Store at room temperature, away from moisture and heat.  Keep out of reach of children.

* **Q:  Are there any specific dietary restrictions while taking Tolvaptan?** A:  Patients should ensure adequate fluid intake. Avoid grapefruit juice.

* **Q:  What are the long-term effects of Tolvaptan?** A: Long-term use is limited to 30 days due to the risk of hepatotoxicity.  Your doctor will determine the appropriate duration of treatment based on your response and condition.  


**Disclaimer:** This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.  The information provided here may not be exhaustive and should not be used as a substitute for professional medical care.
